- KEI welcomes the Gilead HCV licenses, as a step to expand access to treatments. Notes challenges that remain
- Senator Wyden in 2012, on access to the TPP text
- WIPO General Assembly 2014: Hard Decisions on the Broadcast Treaty and work program on copyright limitations and exceptions
- 13 May 2014: WHO Technical Consultation on Innovative Models for New Antibiotics’ Development and Preservation
- TDR and the Pooled Fund for R&D: WHO demonstration projects and CEWG follow-up
- OMB's Revised Guidance on Appointment of Lobbyists to Federal Advisory Committees, Boards, and Commissions
- Gilead's US patient access programs for Sovaldi
- Some recent cancer drug prices
- January 2013: Proposal for the inclusion of trastuzumab in WHO EML for treatment of HER2-Positive Breast Cancer
- Money speaks: USTR releases letters from Congress backing PhRMA on exclusive rights biologic test data in TPP
I woke up this morning to read an article by Karol Sikora, a Dean at the University of Buckingham Medical School, about high cancer drug prices.* This quote caught my eye.
quote: "So cancer drug rationing is inevitable in all health economies – rich and poor alike. My solution is to have age limits for expensive therapies. Oncologists have been doing this covertly for the last two decades – it's now time to be explicit."
Videos from TACD's June 25, 2014 side event on intellectual property in the US, EU trade agreement (TTIP)Submitted by James Love on 26. June 2014 - 5:32
The following are videos from TACD's June 25, 2014 side event on intellectual property and the proposed Transatlantic Trade and Investment Partnership (TTIP) agreement.
On 11 June 2014, India delivered the following statement at the WTO TRIPS Council on on non-violation and situation complaints in response to the US proposal (IP/C/W/599) tabled on 10 June 2014.
WTO TRIPS Council (June 2014): EU on the contribution of IP to facilitate the transfer of environmentally rational technologySubmitted by thiru on 17. June 2014 - 4:07
On Wednesday, 11 June 2014, the European Union delivered the following statement on the "Contribution of IP to facilitate the transfer of environmentally rational technology technology.'
EU intervention under point 11. Of the TRIPS Council Agenda
"Contribution of IP to facilitate the transfer of environmentally rational technology"
KEI has obtained the terms of reference (TOR) for the confidentiality of the negotiating texts of the Transatlantic Trade and Investment Partnership (TTIP) Agreement. The TOR are laid out in a two-page letter from US Chief Negotiator Dan Mullaney to EU Chief Negotiator Ignacio Garcia-Bercero which is available here. The letter was obtained through a FOIA request filed by KEI with the USTR on May 19, 2014.
WTO TRIPS Council (June 2014) - India's intervention on Intellectual Property and Innovation: Innovation IncubatorsSubmitted by thiru on 11. June 2014 - 10:28
On Wednesday, 11 June 2014, India delivered a statement at the WTO TRIPS Council on"Intellectual Property and Innovation: Innovation Incubators"; Chinese Taipei (WTO speak for Taiwan) and the United States proposed this agenda item.
We thank the delegations of the United States and Chinese Taipei for tabling an agenda item on "Intellectual Property and Innovation: Innovation Incubators " which we understand is a standalone item.
WIPO's Patent Cooperation Treaty (PCT) Working Group is meeting from 10 June 2014 to 13 June 2014. Among the hot topics of discussion is a paper tabled by the United Kingdom and the United States on Formal Integration of the Patent Prosecution Highway into the PCT. The basic ask of the UK/US proposal (PCT/WG/7/21) is to amend the regulations of WIPO's PCT Regulations and Administrative Instructions to formally integrate the Patent Prosecution Highway (PPH) into the PCT system.
WTO TRIPS Council (June 2014): USTR submission on Non-Violation Complaints Under the TRIPS AgreementSubmitted by thiru on 11. June 2014 - 1:36
On 10 June 2014, the United States tabled a paper (IP/C/W/599) to the World Trade Organization's (WTO) TRIPS Council on "Non-Violation Complaints Under the TRIPS Agreement." This paper is expected to be discussed at the TRIPS Council today (11 June 2014) under agenda item 7 on "Non-Violation and Situation Complaints."
As previously mentioned in our February 2014 piece,
World Health Assembly (WHA 67) agrees to create pooled R&D fund, endorses delinkage of R&D costs from product pricesSubmitted by James Love on 24. May 2014 - 4:45
Today the World Health Assembly (WHA) reached consensus on a "decision", WHA67(15), regarding the Consultative Expert Working Group (CEWG) on Research and Development.
On Friday, 23 May 2014, the World Health Assembly is currently discussing access to essential medicines in the context of resolution EB134.R16, tabled China in January 2014. The following statement was delivered by South Africa on behalf of the 47 members of the African region. South Africa highlighted the point that "vaccines and anti-cancer drugs remain out of reach of millions of people in both developed and developing countries."
Wednesday, at the George Mason University Law Campus in Arlington, VA, the Office of the US Trade Representative hosted an all day Stakeholder Forum in conjunction with the fifth negotiating round of the Transatlantic Trade and Investment Partnership. The first part of the day was devoted to Stakeholder Policy Presentations, with several hours of presentations by a variety of industry, academics, trade associations, and public interest groups. The latter part of the day consisted of a briefing by the US Chief Negotiator Dan Mullaney and the EU Chief Negotiator Ignacio Garcia-Bercero.
This Wednesday 21 May 2014, Knowledge Ecology International (KEI), Civil Society Coalition, Medecins Sans Frontieres (MSF), Oxfam, Health Action International (HAI) and Treatment Action Group (TAG) will host a side event at the WHA on, "Innovation and Access to Medicines and Vaccines: Emerging Challenges and Opportunities for Middle-Income Countries."
At the opening of the 67th World Health Assembly, today the Young Professionals Chronic Disease Network (YP-CDN), Knowledge Ecology International (KEI), and Universities Allied for Essential Medicines (UAEM) released a briefing, "Cancer medicines are essential in reducing the global burden of non-communicable diseases."
WIPO fails to reach agreement to convene a Diplomatic Conference for adoption of the Design Law TreatySubmitted by thiru on 9. May 2014 - 23:44
On Thursday, 8 May 2014, the General Assembly of the World Intellectual Property Organization (WIPO) appointed Francis Gurry as Director General for a second term. This second term would run from 1 October 2014 to 30 September 2020.
The General Assembly also addressed the following topic: "Consideration of the Convening of a Diplomatic Conference for the Adoption of a Design Law Treaty." At the close of business on Friday, 9 May 2014, the General Assembly could not reach consensus on convening a Diplomatic Conference on concluding the Design Law Treaty.
At 12:56 AM on 3 May 2014, WIPO's Copyright Committee, (SCCR27) could not reach agreement on the future work on "Limitations and exceptions: libraries and archives." The main point of contention was "text-based work" which the European Union sought to excise from the text. Consequently, the Committee was at an impasse in developing an appropriate international legal instrument (in whatever form) on copyright exceptions and limitations for libraries and archives (whether model law, joint recommendation, treaty and/or other forms).